Dr. Oak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
550 First Avenue
New York, NY 10016
Education & Training
NYU Grossman School of MedicineResidency, Neurology, 2020 - 2024- NYU Grossman School of MedicineResidency, Internal Medicine, 2020 - 2021
Washington University in St. Louis School of MedicineClass of 2020
Certifications & Licensure
NY State Medical License 2024 - 2026
Publications & Presentations
PubMed
- 11 citationsMaintenance rituximab every 2 months is more toxic than every 3 months in patients with non-Hodgkin lymphoma.Armin Rashidi, Eunhye Oak, Nancy L. Bartlett
Blood. 2015-05-21 - 54 citationsPredictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study.Narendranath Epperla, Mehdi Hamadani, Amanda F. Cashen, Kwang Woo Ahn, Eunhye Oak
Hematological Oncology. 2017-01-08 - 26 citationsBlinatumomab for the treatment of B-cell lymphomaEunhye Oak, Nancy L. Bartlett
Expert Opinion on Investigational Drugs. 2015-04-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
